US exports to double for BPR Medical
This article was originally published in Clinica
Executive Summary
With US FDA clearance for BPR Medical's Babycare NeO(2) oxygen control system for premature neonates, the UK company expects US exports to account for over half of its total sales overseas. More than 60% of its annual turnover of £500,000 ($780,000) is currently achieved outside the UK, with the Netherlands, Belgium and India representing important markets, says managing director David Baker.